Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FE3A0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,771
Award facts
- Contract value 100% obligated
- $17,770.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $17,770.68 on August 27, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 28, 2025, and performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates capability across multiple therapeutic domains, including specialty medications, biologics, and medical devices. This delivery order for Dupixent, a brand-name biologic medication, exemplifies the company's role in supplying specialty pharmaceutical products through the DLA's Medical Supply Chain to support Defense Health Agency operations and other federal healthcare systems. All AmerisourceBergen awards reviewed were competitively awarded without set-aside designations, reflecting the company's established capacity to meet rigorous federal procurement standards.
Quick answers
Who was awarded contract SPE2DB25FE3A0?
SPE2DB25FE3A0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FE3A0 worth?
The government has obligated $17,771 on SPE2DB25FE3A0.
Is contract SPE2DB25FE3A0 an order under another contract?
Yes. SPE2DB25FE3A0 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE3A0 competed?
The extent of competition for SPE2DB25FE3A0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award